SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-19-037163
Filing Date
2019-06-14
Accepted
2019-06-14 16:49:58
Documents
2
Period of Report
2019-06-13

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1628
2 POA DOCUMENT poa.txt EX-24.3_860190 4000
  Complete submission text file 0001209191-19-037163.txt   7050
Mailing Address 10 NORTH HIGH STREET SUITE 200 WEST CHESTER PA 19380
Business Address 10 NORTH HIGH STREET SUITE 200 WEST CHESTER PA 19380 484-453-3300
Verrica Pharmaceuticals Inc. (Issuer) CIK: 0001660334 (see all company filings)

IRS No.: 463137900 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O VERRICA PHARMACEUTICALS INC. 10 NORTH HIGH STREET, SUITE 200 WEST CHESTER PA 19380
Business Address
Ballaron Craig (Reporting) CIK: 0001779433 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38529 | Film No.: 19899472